An observational study in Acute Coronary Syndrome, Depression and Anxiety, sponsored by First Affiliated Hospital Xi'an Jiaotong University. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-16.
Sponsored by First Affiliated Hospital Xi'an Jiaotong University · Observational
The purpose of this study is to evaluate how depression and/or anxiety could effect the prognosis of the patients post-ACS after PCI.
This trial is a prospective, multi-centric, real-world clinical study. About 5,000 patients with ACS post-PCI will be recruited according to the resource available of each participating center to represent real-world setting. Patients enrolled in the project will accept two-years' follow-up and will be assessed on mortality, cardiovascular events, and severity of depressive or anxiety symptoms using self-rating scales continuously during the trial, in which their treatment for anxiety or depression will also be documented.
1,461 studies on the registry are indexed under Acute Coronary Syndrome; 267 are open to participants now.
This study's planned enrollment of 5,000 is above the median of 500 across 561 observational studies indexed under Acute Coronary Syndrome.
Browse Acute Coronary Syndrome studies →First Affiliated Hospital Xi'an Jiaotong University is the lead sponsor of 306 studies on the registry; 86 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients suffered from acute coronary syndrome after percutaneous coronary intervention
Inclusion criteria
patients suffered from ACS who have undergone PCI without depression or anxiety
patients suffered from post-ACS depression who have undergone PCI
Other: antidepressive and anti-anxiety therapy
patients suffered from post-ACS anxiety who have undergone PCI
Other: antidepressive and anti-anxiety therapy
patients suffered from post-ACS depression with anxiety who have undergone PCI
Other: antidepressive and anti-anxiety therapy
These therapies include antidepressants, antianxiety drugs and psychotherapy. Subjects choose the therapy follow their own will. All of the above-mentioned therapies are identified by experienced psychiatrists in the same center. The treatment information will be recorded in each visit. The study is considered non-interventional, and no antidepressive or anti-anxiety therapies are mandated.
Major Adverse Cardiovascular Events
death, myocardial infarction, stroke, angina pectoris, revascularization.
Time frame: From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months
Depression self-rating scales
results of depression scales assessed by The Patient Health Questionnaire-2 (PHQ-2, scores ≤2 non, \>2 continue PHQ-9) or PHQ-9 (scores ≤4 non, 5\~9 mild, 10\~19 mediate, ≥ 20 severe)
Time frame: From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months
Anxiety self-rating scales
results of anxiety scales assessed by Generalized Anxiety Disorder 2-item(GAD-2, scores ≤2 non, \>2 continue GAD-7) or GAD-7 (scores ≤4 non, 5\~9 mild, 10\~14 mediate, ≥15 severe)
Time frame: From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months
This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
First Affiliated Hospital Xi'an Jiaotong University